Search

everythinglearnresearchcommunity

for

Search:↓

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

IL-18 signaling helps mature Tregs move into the thymus.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

The role of γδT-cells in causing alopecia areata remains unclear.

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Apremilast did not work for treating severe alopecia areata.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

Combination therapies might work better for some vitiligo patients, but results vary.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Anti-CD19 therapy may help treat SLE and NMOSD.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.